Results for tag: "Polypharmacology"

Polypharmacology is a field of drug discovery that focuses on the development of drugs that target multiple biological pathways. It is based on the idea that targeting multiple pathways simultaneously can produce more effective treatments than targeting a single pathway. This approach is particularly useful for treating complex diseases, such as cancer, where multiple pathways are involved. Polypharmacology also has the potential to reduce the side effects of drugs, as targeting multiple pathways can reduce the dose of each drug needed. The polypharmacology market is growing rapidly, driven by the increasing demand for more effective treatments for complex diseases. This has led to increased investment in the development of polypharmacology drugs, as well as the emergence of new companies specializing in this field. Some of the companies in the polypharmacology market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more